60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership [Yahoo! Finance]
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its price target raised by analysts at HC Wainwright from $6.00 to $24.00. They now have a "buy" rating on the stock.
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up [Seeking Alpha]